- Home
- INM vs EAD Comparison
INM vs EAD Comparison
Compare INM & EAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- EAD
- Stock Information
- Founded
- INM 1981
- EAD 2003
- Country
- INM Canada
- EAD United States
- Employees
- INM N/A
- EAD N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- EAD Finance/Investors Services
- Sector
- INM Health Care
- EAD Finance
- Exchange
- INM Nasdaq
- EAD Nasdaq
- Market Cap
- INM 5.0M
- EAD 404.8M
- IPO Year
- INM N/A
- EAD N/A
- Fundamental
- Price
- INM $1.85
- EAD $6.92
- Analyst Decision
- INM
- EAD
- Analyst Count
- INM 0
- EAD 0
- Target Price
- INM N/A
- EAD N/A
- AVG Volume (30 Days)
- INM 105.5K
- EAD 178.9K
- Earning Date
- INM 11-13-2025
- EAD 01-01-0001
- Dividend Yield
- INM N/A
- EAD 8.91%
- EPS Growth
- INM N/A
- EAD N/A
- EPS
- INM N/A
- EAD N/A
- Revenue
- INM $4,942,633.00
- EAD N/A
- Revenue This Year
- INM N/A
- EAD N/A
- Revenue Next Year
- INM N/A
- EAD N/A
- P/E Ratio
- INM N/A
- EAD N/A
- Revenue Growth
- INM 7.50
- EAD N/A
- 52 Week Low
- INM $1.72
- EAD $5.69
- 52 Week High
- INM $8.27
- EAD $6.81
- Technical
- Relative Strength Index (RSI)
- INM 31.68
- EAD 48.41
- Support Level
- INM $2.04
- EAD $6.74
- Resistance Level
- INM $2.14
- EAD $6.92
- Average True Range (ATR)
- INM 0.11
- EAD 0.05
- MACD
- INM -0.03
- EAD 0.01
- Stochastic Oscillator
- INM 10.87
- EAD 79.61
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
About EAD Allspring Income Opportunities Fund
Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.